A comparison of pregnancy prevention programmes in Europe

Authors:
  • IZInge Zomerdijk
    Inge Zomerdijk
  • MSMiriam Sturkenboom
    Miriam Sturkenboom
  • LBLolkje de Jong-Van Den Berg
    Lolkje de Jong-Van Den Berg
  • SSSabine Straus
    Sabine Straus

Abstract
Pregnancy prevention programmes (PPP) can be imposed by regulatory authorities to minimise the risk of exposure to teratogenic drugs during pregnancy, thus preventing congenital anomalies. The objective of this study was to explore the reasons to request PPPs in the EU and the elements that they included.

This publication has 17 references indexed in Scilit: